Sumeet K. Asrani
Baylor University Medical Center
Appearances
DateMay 8, 2023BACKGROUND: Hepatorenal syndrome (HRS) with rapidly deteriorating kidney function can be effectively reversed when treated with terlipressin, the US FDA-approved vasopressin analogue…Presenter
Speakers
Baylor University Medical CenterUniversity of Arkansas for Medical SciencesUniversity of AlbertaColumbia University Medical Center- DateMay 8, 2023SOCIETY: AASLD
Presenter
Baylor University Medical Center - DateMay 18, 2024
Presenter
Baylor University Medical Center - DateMay 21, 2024BACKGROUND: With the recent increase in metabolic liver diseases and viral hepatitis on anti-viral agents, risk stratification biomarkers are urgently needed to identify cirrhosis patients who should be prioritized for hepatocellular carcinoma (HCC) screening for early detection…
Presenter
Speakers
University of MichiganMayo Foundation for Medical Education and ResearchBaylor College of MedicineBaylor University Medical CenterMichael E. DeBakey VAMCBaylor College of MedicineUT Southwestern Medical CenterUniversity of Texas Southwestern Medical Center - DateMay 21, 2024BACKGROUND. Several inflammatory and metabolic biomarkers have been associated with hepatocellular carcinoma (HCC) risk in phase I and II biomarker studies but not in longitudinal studies…
Presenter
Baylor College of MedicineSpeakers
Michael E. DeBakey VAMCBaylor College of MedicineUT Southwestern Medical CenterBaylor University Medical Center 
DateMay 18, 2024IMPROVING ACCESS IN LIVER TRANSPLANTATIONModerators
Baylor University Medical CenterJohns Hopkins University School of MedicineSpeakers
University of Minnesota Academic Health Center
DateMay 18, 2024ACUTE ON CHRONIC LIVER FAILURE AND THE MANAGEMENT OF CRITICALLY ILL PATIENTS WITH CIRRHOSIS + Q&AModerators
Columbia University Medical CenterUniversity of MiamiSpeakers
Baylor University Medical CenterVirginia Commonwealth Univ.
